Company Overview of Inhibiton Therapeutics, Inc.
As of May 5, 2009, Inhibiton Therapeutics, Inc. was acquired by AlumiFuel Power, Inc., in a reverse merger transaction. Inhibition Therapeutics, Inc. engages in the research and development of cancer therapeutic agents and cancer fighting drugs called targeted therapies. The targeted therapies identify molecular causes of cancer and inhibit the signals that cancer cells need to multiply. The company was incorporated in 2000 and is based in Englewood, Colorado.
7315 East Peakview Avenue
Englewood, CO 80111
Founded in 2000
Key Executives for Inhibiton Therapeutics, Inc.
Inhibiton Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|NanoMatrix, Inc.||United States|
|GeneCopoeia, Inc.||United States|
|Protein Genomics, Inc.||United States|
|Anthill Technologies, Inc.||United States|
|Ikaria, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Inhibiton Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.